BioLife Solutions, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioLife Solutions, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $0.00.
- BioLife Solutions, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was -$65.00K.
- BioLife Solutions, Inc. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $0.00.
- BioLife Solutions, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $80.21M.
- BioLife Solutions, Inc. stock issued during period, value, new issues for fiscal 2023 was $10.38M.
- BioLife Solutions, Inc. stock issued during period, value, new issues for fiscal 2020 was $100.12M.
- BioLife Solutions, Inc. stock issued during period, value, new issues for fiscal 2018 was $19.91M.
- BioLife Solutions, Inc. stock issued during period, value, new issues for fiscal 2014 was $13.60M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | -$65.00K 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $10.38M 10-K · filed 2026-02-26 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $100.12M 10-K · filed 2023-03-31 |
| 2020-09-30 | $80.21M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $19.91M 10-Q · filed 2021-08-16 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | $19.91M 10-K · filed 2020-05-15 |
| 2018-09-30 | $19.91M 10-Q · filed 2019-11-12 | |
| 2014-12-31 | $13.60M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |